Van Naarden Jacob

Van Naarden Jacob is listed in filings as EVP at Eli Lilly and Co. This profile follows SEC Form 4 activity through Feb 11, 2026, including 3 public disclosures. Recent filings connect the profile to Eli Lilly and Co (LLY). The current snapshot covers public activity from Feb 3, 2026 to Feb 11, 2026. Reported amounts are shown as $5.1M to $2.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.